The Medicines Company announced earnings results for the fourth quarter ended December 31, 2018. For the fourth quarter, the company announced operating loss was USD 25.732 million compared to USD 160.087 million a year ago. Net loss was USD 42.474 million compared to USD 178.262 million a year ago. Basic loss per share from continuing operations was USD 0.6 compared to USD 2.19 a year ago. Basic loss per share was USD 0.58 compared to USD 2.45 a year ago. For the full year, sales was USD 6.138 million compared to USD 44.789 million a year ago. Operating loss was USD 191.411 million compared to USD 665.096 million a year ago. Net loss was USD 123.156 million compared to USD 708.373 million a year ago. Basic loss per share from continuing operations was USD 3.2 compared to USD 8.4 a year ago. Basic loss per share was USD 1.68 compared to USD 9.79 a year ago.